A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/42 (2006.01) A61K 9/70 (2006.01)

Patent

CA 2370581

The invention relates to novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives. The invention more specifically relates to compositions in the form of a patch comprising a therapeutically efficacious amount of a derivative of 2-isoxazole-8-aminotetraline, especially 1,2,3,4-tetrahydro-8-(5-isoxazolyl)-N-N-diisopropyl-2-naphtalenamine. The invention also relates to a 2-isoxazole-8-aminotetralin derivative, especially 1,2,3,4-tetrahydro-8-(5-isoxazolyl)-N,N-diisopropyl-2-naphtalenamine, which is used to produce a medicament which can be administered transdermally to treat irritable bowel syndrome.

L'invention a pour objet des nouvelles compositions pharmaceutiques comprenant des dérivés de 2-isoxazoles-8-aminotétralines. Elle concerne notamment des compositions sous forme de patch, lequel comprend un dérivé de 2-isoxazole-8-aminotétraline, et en particulier de la 1,2,3,4-tétrahydro-8-(5-isoxazolyl)-N,N-diisopropyl-2-naphtalènamine en quantité thérapeutiquement efficace. Elle concerne aussi l'utilisation d'un dérivé de 2-isoxazole-8-aminotétraline, et en particulier de la 1,2,3,4-tétrahydro-8-(5-isoxazolyl)-N,N-diisopropyl-2-naphtalènamine, pour fabriquer un médicament permettant une administration transdermale, notamment dans le traitement du syndrome du colon irritable.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1827837

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.